Trial record 41 of 527 for: "Primary Peritoneal Carcinoma"
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01570582|
Recruitment Status : Unknown
Verified April 2012 by Taek Sang Lee, Korean Gynecologic Oncology Group.
Recruitment status was: Active, not recruiting
First Posted : April 4, 2012
Last Update Posted : April 4, 2012
Korean Gynecologic Oncology Group
Information provided by (Responsible Party):
Taek Sang Lee, Korean Gynecologic Oncology Group
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||March 2014|
|Estimated Study Completion Date :||March 2014|